American Regent Executive and Leadership Team

Paul Diolosa, the President & Chief Executive Officer at American Regent, directs the overarching corporate strategy and operational vision for the organization. Overseeing the development and supply of sterile injectables, the President & Chief Executive Officer ensures alignment between manufacturing capabilities and the evolving needs of healthcare providers across the United States and Canada. This leadership role involves managing complex relationships within the Daiichi Sankyo Group to drive sustainable growth and market expansion. By prioritizing quality and operational excellence, Paul Diolosa directly impacts the company's ability to deliver critical medications to hospitals and clinics nationwide. Ultimately, Diolosa secures long-term stability by fostering a culture of innovation and rigorous compliance, ensuring that the organization remains a trusted partner in the pharmaceutical industry while navigating the competitive landscape of North American healthcare markets.

Srinivas Tetali, the Chief Medical Officer at American Regent, oversees clinical strategy and medical affairs to ensure the safety and efficacy of the company's sterile injectable portfolio. Managing interactions with regulatory bodies and healthcare professionals, the Chief Medical Officer provides critical guidance on product development and therapeutic applications. This leadership role involves evaluating clinical data to support the introduction of new pharmaceutical solutions into the North American market. By maintaining high standards of medical integrity, Srinivas Tetali directly impacts the company's reputation among clinicians and hospital systems. Ultimately, Tetali drives the scientific mission of the organization, ensuring that every product meets the stringent requirements of modern medicine while supporting the broader goals of the Daiichi Sankyo Group in delivering high-quality care to patients across the United States and Canada.

Joseph Oestreicher, the Chief People Officer at American Regent, directs human capital strategy and organizational development across all manufacturing and corporate locations. Overseeing talent acquisition, employee engagement, and workforce training, the Chief People Officer ensures that the company maintains a highly skilled team capable of producing complex sterile injectables. This leadership role involves aligning internal culture with the broader mission of the Daiichi Sankyo Group to foster innovation and operational efficiency. By implementing robust performance management systems, Joseph Oestreicher directly impacts the productivity and retention of staff throughout New York, Ohio, and Pennsylvania. Ultimately, Oestreicher secures the human infrastructure necessary for sustained growth, ensuring that the organization attracts and retains top-tier talent to support the delivery of essential pharmaceutical products to healthcare providers throughout the North American region.

Gretchen Fritz, the Vice President, Chief Legal Officer at American Regent, directs all legal affairs, corporate governance, and regulatory compliance initiatives. Overseeing risk management and contract negotiations, the Vice President, Chief Legal Officer ensures that the company adheres to the complex legal frameworks governing pharmaceutical manufacturing and distribution. This leadership role involves providing strategic counsel to the executive team regarding intellectual property and industry-specific regulations across the United States and Canada. By mitigating legal exposure, Gretchen Fritz directly impacts the company's ability to operate securely and efficiently in a highly regulated environment. Ultimately, Fritz secures the organization's interests by maintaining rigorous compliance standards, allowing the business to focus on the development and supply of high-quality sterile injectables for hospitals and clinics while upholding the values of the Daiichi Sankyo Group.

Joseph Tedesco, the Vice President, Information Technology at American Regent, directs the digital infrastructure and cybersecurity strategy required to support pharmaceutical manufacturing and supply chain operations. Overseeing the integration of advanced data systems, the Vice President, Information Technology ensures that internal processes remain efficient and secure across all regional facilities. This leadership role involves modernizing technological platforms to enhance communication between manufacturing sites and nationwide sales territories. By optimizing digital workflows, Joseph Tedesco directly impacts the company's operational agility and data integrity. Ultimately, Tedesco secures the technological foundation of the organization, enabling seamless coordination of resources and information to support the delivery of sterile injectables to healthcare providers throughout North America, while ensuring that all systems align with the broader strategic objectives of the Daiichi Sankyo Group.